Indication
Radiofrequency Ablation
4 clinical trials
6 products
1 drug
Clinical trial
Dexmedetomidine-esketamine Combined With Oxycodone for Ultrasound-guided Percutaneous Radiofrequency Ablation in Patients With Liver Cancer: a Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2024-07-01
Product
RemifentanilProduct
OxycodoneClinical trial
Ultrasound-guided Radiofrequency Ablation Versus Radioactive Iodine as Treatment for Hyperthyroidism Caused by Solitary Autonomous Thyroid NodulesStatus: Recruiting, Estimated PCD: 2027-12-01
Product
Radioactive iodineClinical trial
Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency AblationStatus: Terminated, Estimated PCD: 2022-10-14
Product
DexamethasoneDrug
VarlilumabProduct
Hypotensive Drugs